Page last updated: 2024-10-24

cefuroxime and Amnionitis

cefuroxime has been researched along with Amnionitis in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"In an open nonrandomized, dose-response study, nine patients with PROM at 27-33 weeks' gestation received 1."1.29Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes. ( Bouckaert, PX; Cremers, HM; De Leeuw, JW; Roumen, FJ; Vree, TB, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Leeuw, JW1
Roumen, FJ1
Bouckaert, PX1
Cremers, HM1
Vree, TB1

Other Studies

1 other study available for cefuroxime and Amnionitis

ArticleYear
Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes.
    Obstetrics and gynecology, 1993, Volume: 81, Issue:2

    Topics: Adult; Amniotic Fluid; Cefuroxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Dose-Resp

1993